BioCentury
ARTICLE | Distillery Therapeutics

Blocking ATF4 to treat glioblastoma

January 31, 2023 8:18 PM UTC

Inhibiting the transcription factor ATF4, which promotes expression of fructolysis regulators, could help treat glioblastoma multiforme (GBM) by decreasing fructose utilization that drives tumor cell ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article